Playlist
Dashoguz hosts celebrations in honor of the Galkynysh National Equestrian Group’s international victories
20 Feb. 06:42A series of festive events took place in the Dashoguz province to commemorate the global acclaim recently received by the "Galkynysh" national equestrian group. The celebrations kicked off at the Gerogly Square in the city of Dashoguz, featuring dramatic performances by actors from the Nurmuhammet Andalyp State Musical Drama Theater, showcasing the region's artistic heritage.
Members of the "Galkynysh" group visited the Regional Museum of History and Local Lore, where they explored ancient national artifacts that reflect the enduring legacy of the Turkmen people. The main festivities continued at the "Türkmeniň ak öýi" building, where speakers highlighted the Akhal-Teke horse as a quintessential symbol of bravery, elegance, and loyalty, deeply rooted in the nation’s cultural identity.
The highlight of the event was a spectacular performance by the "Galkynysh" group inside the grand hall of "Türkmeniň ak öýi." Following the breathtaking equestrian stunts, a traditional "agzaçar sadakasy" dinner was organized for the participants and guests. These celebrations follow the group's historic achievement at the 48th International Circus Festival of Monte Carlo in January 2026, where they were presented with prestigious certificates from the World Circus Federation and the European Circus Association. The group is currently touring all provinces of Turkmenistan to share this milestone with the entire nation.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz